On November 12th, PW MEDTECH (01358) spent 1.034 million Hong Kong dollars to repurchase 1 million shares.
PwC Holdings Limited (01358) announced on November 12, 2024 that it will spend HK$103.4 million to repurchase its shares.
PW MEDTECH (01358) announced that on November 12, 2024, it will spend 1.034 million Hong Kong dollars to repurchase 1 million shares at a repurchase price of 1.03-1.04 Hong Kong dollars per share.
Related Articles
SHENGLONG INTL (08481) announced its annual performance, with shareholders' net profit reaching 75.848 million yuan, a year-on-year increase of 59.6%.
KINDSTAR GLOBAL (09960) announced its annual performance with a revenue of 934 million yuan, an increase of 0.65% year-on-year. The revenue from the oncology sector achieved a significant growth of 106.2%.
HYBRID KINETIC (01188) announced its annual performance with a net profit attributable to shareholders of HK $36.83 million, turning losses into gains compared to the previous year.
SHENGLONG INTL (08481) announced its annual performance, with shareholders' net profit reaching 75.848 million yuan, a year-on-year increase of 59.6%.
KINDSTAR GLOBAL (09960) announced its annual performance with a revenue of 934 million yuan, an increase of 0.65% year-on-year. The revenue from the oncology sector achieved a significant growth of 106.2%.
HYBRID KINETIC (01188) announced its annual performance with a net profit attributable to shareholders of HK $36.83 million, turning losses into gains compared to the previous year.
RECOMMEND
Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026
Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026
Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026
